BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29909886)

  • 1. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation.
    Morse E; Judson B; Husain Z; Burtness B; Yarbrough W; Sasaki C; Cheraghlou S; Mehra S
    Oral Oncol; 2018 Jul; 82():122-130. PubMed ID: 29909886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival Association.
    Morse E; Berson E; Fujiwara R; Judson B; Mehra S
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):267-276. PubMed ID: 30324861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysis.
    Morse E; Fujiwara RJT; Judson B; Mehra S
    Laryngoscope; 2018 Dec; 128(12):2751-2758. PubMed ID: 29756382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations.
    Morse E; Judson B; Husain Z; Burtness B; Yarbrough WG; Sasaki C; Cheraghlou S; Mehra S
    Otolaryngol Head Neck Surg; 2018 Dec; 159(6):987-997. PubMed ID: 30060700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.
    Self EM; Bumpous J; Ziegler C; Wilson L; Potts K
    JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):356-61. PubMed ID: 23599070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
    Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
    Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer.
    Jacobs D; Torabi SJ; Park HS; Rahmati R; Young MR; Mehra S; Judson BL
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1240-1248. PubMed ID: 33198564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the "violated neck" in the era of chemoradiation.
    Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
    Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinic.
    Light T; Rassi EE; Maggiore RJ; Holland J; Reed J; Suriano K; Stooksbury M; Tobin N; Gross N; Clayburgh D
    Head Neck; 2017 Jun; 39(6):1106-1112. PubMed ID: 28370667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
    Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
    Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
    Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment delays in surgically managed sinonasal cancer and association with survival.
    Goel AN; Lee JT; Wang MB; Suh JD
    Laryngoscope; 2020 Jan; 130(1):2-11. PubMed ID: 30835855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and quality of life in oropharyngeal cancer patients treated with primary chemoradiation after salivary gland transfer.
    Morand GB; Madana J; Da Silva SD; Roskies M; Sultanem K; Black MJ; Mlynarek AM; Hier MP
    J Laryngol Otol; 2016 Aug; 130(8):755-62. PubMed ID: 27339712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.